Through different pharmacodynamic–kinetic interactions, weekly administration of proved efficacy agents can overcome resistance with lower toxicity and greater benefit.
TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC) / Longo, F; Pellegrini, P; Ceccarelli, F; Borgomastro, A; Comito, T; Basile, Maria Luisa; DE BIASIO, G; Girolami, Marco; Spalletta, B; DI SERI, M.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - STAMPA. - 15:(2004), pp. 23-23. [101093]
TOXICITY OF WEEKLY LIPOSOMAL DOXORUBICIN AND PACLITAXEL IN METASTATIC BREAST CANCER (MBC)
BASILE, Maria Luisa;GIROLAMI, Marco;
2004
Abstract
Through different pharmacodynamic–kinetic interactions, weekly administration of proved efficacy agents can overcome resistance with lower toxicity and greater benefit.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
